AIRS

AirsculptB

Nasdaq / Health Care Equipment & Services

At close

2026-06-02

View Chart

AI scenario view

RankAlpha Sentiment Codex

B+

Bull case

30%

Probability

Target price

$5.50

+5.4% vs current

Most likely

Base case

45%

Probability

Target price

$4.10

-21.5% vs current

B-

Bear case

25%

Probability

Target price

$2.10

-59.8% vs current

AI sentiment snapshot

Latest data as of 2026-05-04

AI commentary

Recent coverage appears sparse and mostly earnings-summary style, which fits the low-coverage profile. Primary-source support is adequate because the April 2, 2026 8-K earnings release and the March 31, 2026 10-K establish the key stabilization, guidance, liquidity, and maturity facts. With no usable social-context packet and no visible post-print analyst-revision set in the packet, this remains a cautious monitoring view rather than a high-conviction rerating call.

RankAlpha Sentiment Codex - 2026-05-04

Open full AI memo

Evidence flagged

No evidence quality warning is currently attached to this memo.

Impact

standard

Confidence

AI events

2026-05-12catalystMay 12 annual meeting is the nearest company-dated checkpoint after the April stabilization updateHigh impact

The April 2, 2026 earnings release said same-store sales turned positive in February, guided first-quarter 2026 revenue to $38.5-$39.5 million with approximately flat same-store revenue at the midpoint, and moved the annual meeting to May 12, 2026. For a low-coverage name, that meeting is the nearest dated checkpoint for whether management still frames demand and conversion as stabilizing rather than deteriorating [#8-K-2026-04-02].

2026-12-31catalystA stronger rerating still needs multiple quarters of procedure and revenue follow-throughHigh impact

The 2025 10-K and April 2, 2026 earnings release show 2025 case volume fell 15.6% to 11,852, revenue fell 15.8% to $151.8 million, and adjusted EBITDA declined to $15.1 million, while 2026 guidance of roughly $151-$157 million revenue and $15-$17 million adjusted EBITDA still reads more like stabilization than a clear growth breakout [#10-K-2026-03-31][#8-K-2026-04-02].

2027-05-11eventBalance-sheet de-risking before the May 2027 debt maturity remains a major equity sensitivityHigh impact

The 10-K says the term loan and revolving credit facility mature on May 11, 2027. At December 31, 2025 the company had $8.4 million of cash and $5.0 million of revolver availability, and the April 2, 2026 release said first-quarter ATM proceeds of $14.8 million helped reduce gross debt to about $45.0 million. That helps near-term liquidity, but refinancing execution and further dilution risk remain material [#10-K-2026-03-31][#8-K-2026-04-02].

View full catalyst timeline

Recommendation

N/A

No formal recommendation provided.

Open AI Memo

As of 2026-05-04 • Updated nightlySource: Internal modelMethodology